FIRST TIME VISITOR? CLICK HERE!

Welcome to AIDS-Drugs-Online.com.

Our website ensures an easy ordering process for affordable HIV/AIDS and PrEP medications, as well as protection of our customers' information. Having an account on our website allows you to place your orders easily, upload your prescriptions safely, view your order history, and even earn discounts.

If you have not ordered from us before:
You can create an account for free by clicking here.

Please take a moment to learn how to order. If you have any trouble, please call us at 1-888-243-7675.

Australia: +61 (2) 90537441 Switzerland: +41 (44) 7982088

We invite you to explore our website and save money on your HIV/AIDS and PrEP medications!


Descovy 200/25mg
30 tablet(s)

Descovy 200/25mg

$924.99 USD
+ shipping and handling
0 Review(s)

Prescription required

Active Ingredient(s): emtricitabine/tenofovir alafenamide
Manufacturer: Gilead Science Inc.
Brand: Yes
Country of origin: Canada
30 tablet(s)
Active Ingredient(s): emtricitabine/tenofovir alafenamide
Manufacturer: Gilead Science Inc.
Brand: Yes
Country of origin: Canada
Knows Names:

DESCOVY is a combination formulation of the NRTI (Nucleoside and Nucleotide Reverse Transcriptase Inhibitor) drugs emtricitabine (200mg) and tenofovir alafenamide (25mg). It is used to treat HIV in patients without a Hepatitis B virus (HBV) or Hepatitis C virus (HCV) co-infection.  DESCOVY contains tenofovir alafenamide, which is a newer formulation of the NRTI tenofovir disoproxil fumarate.  There are differences in the drug as tenofovir alafenamide, the version present in DESCOVY, has a reduced amount of side effects.

Dosing & Administration

DESCOVY is used to treat HIV in adults and children (weighing at least 25 kg), in combination with other antiretroviral medications. DESCOVY comes in a film-coated oral tablet.  The tablet should be taken once a day, with or without food.

Patients with mild to moderate liver dysfunction do not require dosage adjustments. DESCOVY should not be used if the creatinine clearance is less than 30 mL/min, however dosage adjustments are not required in renal dysfunction.  Details about dosage are explained in the package insert.

Contraindications

DESCOVY is contraindicated in patients with hypersensitivity to the drug.

Side Effects

DESCOVY is associated with hepatotoxicity and with reduced bone mineral density (BMD). Other possible side effects include osteonecrosis, body fat redistribution, increased cholesterol, immune reactivation syndrome, and nausea. More details about potential side effects are listed in the package insert.

Precautions

DESCOVY should not be used in HIV patients who are co-infected with HBV of HCV due to increased risk of hepatotoxicity.  It is not indicated for the treatment of HBV infection.

Patients who test positive for HIV should be screened for a comorbid HBV infection.  Regardless of CD4 counts or HBV viral loads, co-infected patients should be started on an antiretroviral regimen targeting both viruses. Drug regimens and prescribing considerations are outlined in the current HIV treatment guidelines.

Current HIV treatment guidelines recommend testing for comorbidity between HIV and HCV.  Ongoing testing for those at high risk is recommended. If co-infection is identified, treating both infections concurrently should be considered.

Patients who develop lactic acidosis or hepatomegaly should have their DESCOVY therapy suspended.  Further details about monitoring recommendations and screening are available in the package insert.

There is the risk of reduced BMD while taking DESCOVY, so BMD monitoring should be considered.

Drug Interactions

There are potential drug-to-drug and herbal interactions listed with DESCOVY.  Details are provided in the package insert.  

Pregnancy & Lactation

Effects of DESCOVY in pregnancy are not yet know, so current guidelines should be consulted before using DESCOVY in pregnant women.  All pregnant women with HIV should use a highly active retroviral combination treatment. Since it is not determined whether DESCOVY is transmitted through breast milk, breastfeeding is to be avoided.

Overdosage

The use of close observation and standard supportive measures should be used in the case of a DESCOVY overdose.  Both active ingredients of DESCOVY are partially dialyzed.

There are no reviews yet
Be the first to review “Descovy 200/25mg”
Star

Reviews are only written by verified customers who have purchased this product.

Related Products

Tenvir EM

Tenvir EM

from $65.00 USD
Abamune-L 600/300 Mg

Abamune-L 600/300 Mg

from $98.00 USD
Viraday

Viraday

from $98.00 USD
Efavir 600mg

Efavir 600mg

from $65.00 USD

Reset your password

Please enter your email below, and we will send you a new password.

Still having trouble signing in?

If you're unable to reset your password, please call Customer Service at 1-888-243-7675.